Ardan Pharma is a biotechnology startup whose main objective is the discovery and development of new immunotherapies for cancer treatments.

It was funded by a multidisciplinary scientific team with more than 10 years of experience in the comprehensive study and manipulation of the Immune System.

This strength, paired with the team’s entrepreneurial spirit, has led the company to obtain a portfolio of compounds that have the potential to be new cancer drugs.

Ardan has demonstrated its therapeutic efficacy in several in vivo models, and has undergone toxicological characterization, with the prospect of reaching clinical evaluation in humans.